- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | FDA grants emergency authorization to COVID-19 convalescent plasma | ||
| Di | Moderna scaling up ex-US COVID-19 vaccine capacity as EU deal nears | ||
| Di | Bavarian Nordic's freeze-dried smallpox vaccine clears clinical test | ||
| Mo | AbCellera buys OrthoMab platform to move into bispecifics | ||
| Mo | CureVac advances talks to sell 405m COVID-19 vaccines to EU | ||
| Mo | MaaT starts manufacturing campaign after France lifts COVID-19-related restrictions | ||
| Do | Roche, Regeneron ally to triple supply of COVID-19 antibody cocktail | ||
| Do | FDA rejection of BioMarin gene therapy raises durability questions | ||
| Do | Analyst tips first wave of COVID-19 vaccines to generate $20b | ||
| 18.08. | AdComm backs Mesoblast cell therapy despite manufacturing concerns | ||
| 18.08. | AstraZeneca, J&J and Sanofi-GSK set to sell up to 1.1bn COVID-19 vaccines to EU | ||
| 18.08. | CDC tasks McKesson with distributing COVID-19 vaccines in US | ||
| 17.08. | UK strikes deals with J&J, Novavax to source 90m COVID-19 vaccines | ||
| 17.08. | AstraZeneca targets 25% jump in US flu vaccine shipments | ||
| 17.08. | Gates Foundation gives Dynavax COVID-19 grant to scale up adjuvant production | ||
| 13.08. | CureVac files for Nasdaq IPO to fund COVID-19 vaccine development | ||
| 13.08. | Moderna lands US COVID-19 vaccine contract worth up to $8bn | ||
| 13.08. | Ligand inks $438m Pfenex buyout to add protein expression tech to portfolio | ||
| 11.08. | Gates Foundation commits $150m to make COVID-19 vaccines for $3 a dose | ||
| 11.08. | COVID-19 drives 20% growth at Merck KGaA's process solutions unit | ||
| 11.08. | Regeneron targets September data drop from COVID-19 antibody trial | ||
| 10.08. | Moderna makes commercial case for COVID-19 vaccine amid price pressure | ||
| 10.08. | Allogene CAR-T plant on track despite 'minor delays' due to COVID-19 | ||
| 10.08. | Fate touts potential to make 15,000 cell therapy doses per cGMP run | ||
| 06.08. | Incyte bullish about virtual launch of rival to CAR-T therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
